T1	Task 0 33	Mice bearing the orthotopic model
T2	Task 91 128	mice with the pseudo-metastatic model
T3	Process 231 247	test the effects
T4	Material 251 276	our targeted formulations
T5	Task 186 213	These therapeutic schedules
T6	Material 324 342	preclinical models
T7	Task 378 385	Animals
T8	Material 433 443	untargeted
T9	Material 457 481	peptide-targeted SL[DXR]
T10	Material 616 637	HEPES-buffered saline